InvestorsHub Logo
Followers 55
Posts 2608
Boards Moderated 0
Alias Born 02/04/2014

Re: frosr6 post# 39398

Saturday, 08/15/2015 12:29:01 PM

Saturday, August 15, 2015 12:29:01 PM

Post# of 144814
Yes, they can purchase Cell in a Box and use it with their own drugs in preclinical studies but going further would infringe on "third party rights" (PMCB).

"Legal Information

(a)This product shall only be used for research purposes. Purchaser shall not use the product to manufacture commercial products and/or to sell services relating to or using the product.
(b) Sigma Aldrich does not grant to purchaser any license, express or implied, in violation of or infringing upon any third party rights. Purchaser is responsible for determining the existence of any such third party rights and to acquire any such rights, should they exist, before using the product.
(c) Purchaser acknowledges and agrees that the product is not intended for use in humans, and agrees not to conduct research with it in humans."

And it was our CEO who said we have NDAs...

"But with the prospect of large trials looming down the road, the company also is assessing the interest of big pharmas, and many have signed nondisclosure agreements. " Ken Waggoner

http://www.bioworld.com/content/pharmacyte-seeks-solve-pancreas-puzzle-cell-box
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News